Document Detail


Retinoid therapy of pigmentary disorders.
MedLine Citation:
PMID:  17014483     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Topical retinoids such as all-trans-retinoic acid (RA), 13-cis-retinoic acid (isotretinoin), retinol, retinaldehyde, tazarotene, and adapalene have been shown to improve dyspigmentation of photodamaged skin including mottling and actinic lentigines. RA monotherapy has also been demonstrated to improve melasma and postinflammatory hypermelanosis. Furthermore, RA in combination with hydroquinone or 4-hydroxyanisole, or azelaic acid increases the potency of depigmenting agents for the treatment of melasma, actinic lentigines, and postinflammatory hypermelanosis. The basic mechanisms underlying these effects are not completely identified. Topical retinoids stimulate the cell turn-over of epidermal keratinocytes and promote a decrease in melanosome transfer and a rapid loss of melanins via epidermopoiesis. Topical retinoids are also involved in the control of cell differentiation. Retinoid-induced changes in the stratum corneum and the permeability barrier may also facilitate the penetration of depigmenting agents in the epidermis and increase their bioavailability, leading to increased depigmentation. In addition, several in vitro studies demonstrate that cis and trans-retinoic acid inhibit UV-B stimulated melanogenesis in term of tyrosinase activity and melanin synthesis. It is likely that topical retinoids modulate epidermal melanin count via a direct action on melanocytes and epidermal keratinocytes.
Authors:
Jean-Paul Ortonne
Related Documents :
12125723 - Inhibition of retinoid activity by components of a paper mill effluent.
8534203 - Low serum concentration of all-trans and 13-cis retinoic acids in patients treated with...
12125723 - Inhibition of retinoid activity by components of a paper mill effluent.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Dermatologic therapy     Volume:  19     ISSN:  1396-0296     ISO Abbreviation:  Dermatol Ther     Publication Date:    2006 Sep-Oct
Date Detail:
Created Date:  2006-10-03     Completed Date:  2007-01-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9700070     Medline TA:  Dermatol Ther     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  280-8     Citation Subset:  IM    
Affiliation:
Service de Dermatologie, Hôpital l'Archet Nice Cedex 3, France. ortonne@unice.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Pigmentation Disorders / drug therapy*
Retinoids / therapeutic use*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Retinoids

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Update in retinoid therapy of acne.
Next Document:  Retinoids in cosmeceuticals.